Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?

by Asaf Levartovsky, Yiftach Barash, Shomron Ben-Horin, Bella Ungar, Eyal Klang, Shelly Soffer, Uri Kopylov
Published 2020-08-01

Predictors of mortality in inflammatory bowel disease patients treated for pneumonia

by Offir Ukashi, Yifatch Barash, Michael J. Segel, Bella Ungar, Shelly Soffer, Shomron Ben-Horin, Eyal Klang, Uri Kopylov
Published 2020-07-01

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study

by Ido Veisman, Oranit Barzilay, Liora Bruckmayer, Ola Haj-Natour, Uri Kopylov, Rami Eliakim, Shomron Ben-Horin, Bella Ungar
Published 2021-09-01

Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study

by Hussein Mahajna, Yiftach Barash, Bella Ungar, Shelly Soffer, Ahmad Albshesh, Asaf Levartovsky, Shomron Ben-Horin, Eyal Klang, Uri Kopylov
Published 2020-11-01

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists

by Anna Vaisman-Mentesh, Shai Rosenstein, Miri Yavzori, Yael Dror, Ella Fudim, Bella Ungar, Uri Kopylov, Orit Picard, Aya Kigel, Shomron Ben-Horin, Itai Benhar, Yariv Wine
Published 2019-12-01